Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics, Inc.

NTLA Clue Score53
United States Fiscal year ends December CIK 0001652130
13.07
+3.73%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
13.07 on 9 Oct 2026
28 18 8 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $23.76 14 Oct 2025 $23.90 15 Oct 2025 $25.93 16 Oct 2025 $24.91 17 Oct 2025 $24.75 20 Oct 2025 $27.98 21 Oct 2025 $26.97 22 Oct 2025 $24.58 23 Oct 2025 $25.89 24 Oct 2025 $25.60 27 Oct 2025 $14.79 28 Oct 2025 $13.96 29 Oct 2025 $13.12 30 Oct 2025 $12.27 31 Oct 2025 $12.62 3 Nov 2025 $13.07 4 Nov 2025 $12.20 5 Nov 2025 $13.57 6 Nov 2025 $12.32 7 Nov 2025 $9.52 10 Nov 2025 $9.73 11 Nov 2025 $10.18 12 Nov 2025 $9.49 13 Nov 2025 $8.67 14 Nov 2025 $8.70 17 Nov 2025 $8.48 18 Nov 2025 $8.47 19 Nov 2025 $8.24 20 Nov 2025 $8.04 21 Nov 2025 $8.21 24 Nov 2025 $8.35 25 Nov 2025 $8.55 26 Nov 2025 $8.52 28 Nov 2025 $8.99 1 Dec 2025 $8.42 2 Dec 2025 $8.10 3 Dec 2025 $9.06 4 Dec 2025 $9.74 5 Dec 2025 $9.61 8 Dec 2025 $9.44 9 Dec 2025 $9.30 10 Dec 2025 $9.37 11 Dec 2025 $9.55 12 Dec 2025 $9.02 15 Dec 2025 $9.14 16 Dec 2025 $9.12 17 Dec 2025 $8.79 18 Dec 2025 $8.88 19 Dec 2025 $9.23 22 Dec 2025 $9.70 23 Dec 2025 $9.42 24 Dec 2025 $9.59 26 Dec 2025 $9.44 29 Dec 2025 $9.14 30 Dec 2025 $9.06 31 Dec 2025 $8.99 2 Jan 2026 $9.21 5 Jan 2026 $9.37 6 Jan 2026 $9.73 7 Jan 2026 $10.13 8 Jan 2026 $10.52 9 Jan 2026 $10.38 12 Jan 2026 $11.43 13 Jan 2026 $11.74 14 Jan 2026 $12.02 15 Jan 2026 $11.87 16 Jan 2026 $12.50 20 Jan 2026 $12.83 21 Jan 2026 $14.03 22 Jan 2026 $15.90 23 Jan 2026 $14.63 26 Jan 2026 $13.95 27 Jan 2026 $14.83 28 Jan 2026 $13.82 29 Jan 2026 $13.90 30 Jan 2026 $13.15 2 Feb 2026 $13.06 3 Feb 2026 $13.05 4 Feb 2026 $12.36 5 Feb 2026 $11.09 6 Feb 2026 $12.28 9 Feb 2026 $12.49 10 Feb 2026 $11.91 11 Feb 2026 $12.00 12 Feb 2026 $11.62 13 Feb 2026 $11.87 17 Feb 2026 $12.22 18 Feb 2026 $12.48 19 Feb 2026 $13.04 20 Feb 2026 $12.64 23 Feb 2026 $13.16 24 Feb 2026 $13.58 25 Feb 2026 $13.42 26 Feb 2026 $14.28 27 Feb 2026 $13.78 2 Mar 2026 $15.44 3 Mar 2026 $13.61 4 Mar 2026 $13.82 5 Mar 2026 $13.15 6 Mar 2026 $13.44 9 Mar 2026 $13.89 10 Mar 2026 $13.47 11 Mar 2026 $13.01 12 Mar 2026 $12.85 13 Mar 2026 $12.76 16 Mar 2026 $13.38 17 Mar 2026 $13.48 18 Mar 2026 $13.21 19 Mar 2026 $13.15 20 Mar 2026 $12.84 23 Mar 2026 $13.11 24 Mar 2026 $12.81 25 Mar 2026 $13.26 26 Mar 2026 $13.24 27 Mar 2026 $12.37 30 Mar 2026 $11.65 31 Mar 2026 $12.82 1 Apr 2026 $13.27 2 Apr 2026 $13.13 6 Apr 2026 $13.30 7 Apr 2026 $13.55 8 Apr 2026 $13.87 9 Apr 2026 $13.83 10 Apr 2026 $13.49 13 Apr 2026 $14.26 14 Apr 2026 $14.78 15 Apr 2026 $14.94 16 Apr 2026 $14.16 17 Apr 2026 $14.95 20 Apr 2026 $15.21 21 Apr 2026 $15.31 22 Apr 2026 $16.57 23 Apr 2026 $15.87 24 Apr 2026 $13.63 27 Apr 2026 $13.04 28 Apr 2026 $13.20 29 Apr 2026 $12.45 30 Apr 2026 $13.48 1 May 2026 $13.26 4 May 2026 $13.87 5 May 2026 $13.31 6 May 2026 $13.85 7 May 2026 $13.71 8 May 2026 $14.09 11 May 2026 $14.42 12 May 2026 $13.99 13 May 2026 $14.28 14 May 2026 $13.09 15 May 2026 $13.67 18 May 2026 $12.69 19 May 2026 $11.94 20 May 2026 $12.26 21 May 2026 $12.37 22 May 2026 $12.60 26 May 2026 $12.61 27 May 2026 $13.44 28 May 2026 $13.68 29 May 2026 $14.07 1 Jun 2026 $13.73 2 Jun 2026 $13.13 3 Jun 2026 $13.02 4 Jun 2026 $14.75 5 Jun 2026 $13.54 8 Jun 2026 $13.49 9 Jun 2026 $12.89 10 Jun 2026 $12.20 11 Jun 2026 $12.35 12 Jun 2026 $12.11 15 Jun 2026 $14.92 16 Jun 2026 $14.55 17 Jun 2026 $15.20 18 Jun 2026 $15.67 22 Jun 2026 $15.75 23 Jun 2026 $15.25 24 Jun 2026 $15.50 25 Jun 2026 $16.03 26 Jun 2026 $16.68 29 Jun 2026 $16.61 30 Jun 2026 $16.92 1 Jul 2026 $17.24 2 Jul 2026 $17.56 6 Jul 2026 $17.84 7 Jul 2026 $17.43 8 Jul 2026 $16.84 9 Jul 2026 $15.44 10 Jul 2026 $14.22 13 Jul 2026 $13.02 14 Jul 2026 $13.30 15 Jul 2026 $13.04 16 Jul 2026 $11.86 17 Jul 2026 $11.38 20 Jul 2026 $10.92 21 Jul 2026 $11.47 22 Jul 2026 $11.13 23 Jul 2026 $11.10 24 Jul 2026 $10.73 27 Jul 2026 $10.67 28 Jul 2026 $10.89 29 Jul 2026 $10.80 30 Jul 2026 $11.09 31 Jul 2026 $10.68 3 Aug 2026 $10.77 4 Aug 2026 $11.32 5 Aug 2026 $10.97 6 Aug 2026 $11.24 7 Aug 2026 $11.94 10 Aug 2026 $12.02 11 Aug 2026 $12.02 12 Aug 2026 $12.09 13 Aug 2026 $11.83 14 Aug 2026 $11.91 17 Aug 2026 $12.09 18 Aug 2026 $11.60 19 Aug 2026 $13.28 20 Aug 2026 $12.44 21 Aug 2026 $12.84 24 Aug 2026 $12.56 25 Aug 2026 $13.51 26 Aug 2026 $13.19 27 Aug 2026 $13.11 28 Aug 2026 $12.87 31 Aug 2026 $12.73 1 Sep 2026 $12.69 2 Sep 2026 $12.76 3 Sep 2026 $12.68 4 Sep 2026 $12.74 8 Sep 2026 $12.74 9 Sep 2026 $12.21 10 Sep 2026 $11.93 11 Sep 2026 $11.74 14 Sep 2026 $11.87 15 Sep 2026 $11.36 16 Sep 2026 $11.49 17 Sep 2026 $12.26 18 Sep 2026 $12.14 21 Sep 2026 $12.22 22 Sep 2026 $12.69 23 Sep 2026 $12.33 24 Sep 2026 $12.16 25 Sep 2026 $11.75 28 Sep 2026 $11.42 29 Sep 2026 $12.03 30 Sep 2026 $12.06 1 Oct 2026 $12.12 2 Oct 2026 $12.26 5 Oct 2026 $12.75 6 Oct 2026 $12.37 7 Oct 2026 $11.71 8 Oct 2026 $12.60 9 Oct 2026 $13.07 LEONARD JOHN M President and CEO Sold on a plan $836.38K 11 Dec 2025 · at $9.49 · 7.8% of stake Dube Michael P VP, Chief Accounting Officer Sold at will $27.53K 5 Jan 2026 · at $9.21 · 5.4% of stake Dulac Edward J III EVP, Chief Financial Officer Sold at will $58.75K 5 Jan 2026 · at $9.21 · 6.0% of stake Schultes Birgit C EVP, Chief Scientific Officer Sold at will $78.36K 5 Jan 2026 · at $9.21 · 7.9% of stake Clark Eliana EVP, Chief Technical Officer Sold at will $87.63K 5 Jan 2026 · at $9.21 · 9.8% of stake BASTA JAMES EVP, General Counsel Sold at will $95.76K 5 Jan 2026 · at $9.21 · 9.3% of stake Lebwohl David EVP, Chief Medical Officer Sold at will $109.63K 5 Jan 2026 · at $9.21 · 8.9% of stake LEONARD JOHN M President and CEO Sold at will $314.48K 5 Jan 2026 · at $9.21 · 3.3% of stake Cohen Fred E Director Bought $1.40M 5 Jan 2026 · at $9.35 · 261% of stake Clark Eliana EVP, Chief Technical Officer Sold at will $8.36K 2 Mar 2026 · at $13.78 · 0.6% of stake BASTA JAMES EVP, General Counsel Sold at will $16.69K 2 Mar 2026 · at $13.78 · 0.8% of stake Dube Michael P VP, Chief Accounting Officer Sold at will $44.32K 1 Jul 2026 · at $16.78 · 3.8% of stake Dulac Edward J III EVP, Chief Financial Officer Sold on a plan $84.19K 2 Jul 2026 · at $18.00 · 2.9% of stake Dulac Edward J III EVP, Chief Financial Officer Sold at will $91.25K 22 Jul 2026 · at $11.25 · 5.2% of stake LEONARD JOHN M President and CEO Sold on a plan $250.61K 20 Aug 2026 · at $12.60 · 1.7% of stake LEONARD JOHN M President and CEO Sold on a plan $36.21K 21 Aug 2026 · at $13.00 · 0.2% of stake Dube Michael P VP, Chief Accounting Officer Sold at will $23.17K 2 Oct 2026 · at $12.43 · 2.8% of stake
1 buy12 sales at will4 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$67.67M
Net income
$412.69M
Free cash flow
$395.87M
Operating margin
-651.7%
Net margin
-609.9%
Return on equity
-61.5%
Return on capital
-51.9%
Revenue growth, 1 yr
16.9%
Revenue growth, 5 yr
3.1% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
58M -134M FY20 Fiscal year 2020 Revenue $57.99M Net income $134.23M Margin -231.5% 33M -268M FY21 Fiscal year 2021 Revenue $33.05M Net income $267.89M Margin -810.5% · growth -43.0% 52M -474M FY22 Fiscal year 2022 Revenue $52.12M Net income $474.19M Margin -909.8% · growth +57.7% 36M -481M FY23 Fiscal year 2023 Revenue $36.28M Net income $481.19M Margin -1,326.5% · growth -30.4% 58M -519M FY24 Fiscal year 2024 Revenue $57.88M Net income $519.02M Margin -896.8% · growth +59.6% 68M -413M FY25 Fiscal year 2025 Revenue $67.67M Net income $412.69M Margin -609.9% · growth +16.9%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
2 Oct 2026 Dube Michael P
VP, Chief Accounting Officer
Sold at will $23.17K 2.8%
21 Aug 2026 LEONARD JOHN M
President and CEO
Sold on a plan $36.21K 0.2%
20 Aug 2026 LEONARD JOHN M
President and CEO
Sold on a plan $250.61K 1.7%
22 Jul 2026 Dulac Edward J III
EVP, Chief Financial Officer
Sold at will $91.25K 5.2%
2 Jul 2026 Dulac Edward J III
EVP, Chief Financial Officer
Sold on a plan $84.19K 2.9%
1 Jul 2026 Dube Michael P
VP, Chief Accounting Officer
Sold at will $44.32K 3.8%